´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ 44th Korean College of Rheumatolgy Annual Scientific Meeting and the 18th International Symposium (KCR2024)-µÑ°³¯ : 2024-05-17
±³À°ÀÏÀÚ : 2024-05-17
±³À°Àå¼Ò : ÄÜ·¡µå ¼¿ï
±³À°ÁÖÁ¦ : (¿Â.¿ÀÇÁ º´Çà) 44th Korean College of Rheumatolgy Annual Scientific Meeting and the 18th International Symposium (KCR2024)-µÑ°³¯
ÁÖÃÖ±â°ü : ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ
´ã´çÀÚ : ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ
¿¬¶ôó : 02-794-2630
À̸ÞÀÏ : webmaster@rheum.or.kr
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Á¤Çü¿Ü°ú, ¿µ»óÀÇÇаú, ÀçÈ°ÀÇÇаú, °¡Á¤ÀÇÇаú
Âü¼®¿¹»óÀÎ : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 19 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 250,000¿ø
ºñ°í »çÀüµî·Ï ȸ¿ø Àü¹®ÀÇ ÀüÀÓÀÇ 180,000¿ø, ºñȸ¿ø Àü¹®ÀÇ ÀüÀÓÀÇ 230,000¿ø ÇöÀåµî·Ï ȸ¿ø Àü¹®ÀÇ ÀüÀÓÀÇ 200,000¿ø, ºñȸ¿ø Àü¹®ÀÇ ÀüÀÓÀÇ 250,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 08:00~08:40 Optimizing Patient Care in Axial Spondyloarthritis ÀÌÁÖÇÏ(°¡Å縯´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 09:00~10:00 Navigating the Expansive Landscape of Future Therapy in Rheumatoid Arthritis Daniel Aletaha(Medical Univ. of Vienna, Austria)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 10:30~11:00 Infectious Complications during Targeted Therapy for Rheumatic Diseases Masayoshi Harigai(Tokyo Women¡¯s Medical Univ., Japan)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 11:00~11:30 H. zoster Infection in Rheumatic Disease Jeffrey R Curtis(The Univ. of Alabama at Birmingham, USA)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 11:30~12:00 Pneumocystis Pneumonia in Rheumatic Disease: A Focus on Prophylaxis Strategies ¹ÚÁØ¿ø(¼¿ï´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 12:00~12:40 What We Have Learned and What We Need Find Out from TNF Inhibition for Chronic ÀÌÀº¿µ(¼¿ï´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 13:00~13:30 Integrating symptom tracking into clinical care William Dixon(Manchester Univ. UK)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 13:30~14:00 How to incorporate rheumatoid arthritis specialized telemedicine enabled by IoT and AI Atsushi Kawakami(Nagasaki Univ., Japan)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 14:00~14:30 Digital health strategies to optimize clinical research and care in rheumatology Jeffrey R Curtis(Univ. of Alabama, USA)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 15:30~15:40 (±¸¿¬ ¹ßÇ¥) Clinical relevance of the systemic lupus erythematosus disease activity score (SLE-DAS) in predicting lupus outcomes: A 5-year longitudinal cohort study °ÁöÇå(Àü³²´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 15:40~15:50 (±¸¿¬ ¹ßÇ¥) Monitoring disease activity and treatment response in Korean patients with systemic lupus ±èÁö¿ø (¾ÆÁÖ´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 15:50~16:00 (±¸¿¬ ¹ßÇ¥) Elevated risk of bacterial meningitis in systemic lupus erythematosus patients and investigation of risk factors in Taiwan: A nationwide population-based study Han Cheng (Immunology and Allergy, Tri-Service General Hosp., Nat)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 16:00~16:10 (±¸¿¬ ¹ßÇ¥) Antiphospholipid syndrome in pediatric lupus- clinico- laboratory manifestation and long term follow up - a 25 years experience from Northwest India Abarna Thangaraj(Advance Pediatric Centre, PGIMER, Chandigarh, India)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 16:10~16:20 (±¸¿¬ ¹ßÇ¥) Hyperuricemia as a prognostic marker for antiphospholipid syndrome: a cohort study of Chinese patients Liang Luo(The People)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 16:30~16:40 (±¸¿¬ ¹ßÇ¥) Predictors of renal function preservation in non-responders to induction therapy for proliferative lupus nephritis ±è¿µÀº(¿ï»ê´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 16:40~16:50 (±¸¿¬ ¹ßÇ¥) Lupus flare and recurrent lupus nephritis following kidney transplantation in patients with lupus nephritis ±è¿µÀº(¿ï»ê´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 16:50~17:00 (±¸¿¬ ¹ßÇ¥) Long-term outcomes of male patients with lupus nephritis compared with female patients ÀüÈ£¿í(°¡Å縯´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 17:00~17:10 (±¸¿¬ ¹ßÇ¥) Effect of renin-angiotensin-system inhibitors on renal remission in lupus nephritis: A real-world study Xiaohui Zhang (Peking Univ. First Hospital, China)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 17:10~17:20 (±¸¿¬ ¹ßÇ¥) Unveiling a novel trend: Belimumab amplifies retinal microvascular density decline in lupus nephritis patients revealed by optical coherence tomography angiography Maierhaba Maitiyaer (The Second Affiliated Hosp. of Guangzhou Medical Univ., Guangzhou, Guangdong, China)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 08:00~08:40 A Well-balanced JAKi from Efficacy and Safety Perspectives. ¼Ò¹Î¿í(ºÎ»ê´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 10:30~10:40 (±¸¿¬ ¹ßÇ¥) Difficult-to-treat rheumatoid arthritis among elderly RA from the KOBIO registry Á¤ÁÖ¾ç(¾ÆÁÖ´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 10:40~10:50 (±¸¿¬ ¹ßÇ¥) Validation of Boolean 2.0 criteria for assessing remission and predicting quality of life in Korean Patients with Rheumatoid Arthritis Undergoing Targeted Therapy Á¶¼ö°æ(ÇѾç´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 10:50~11:00 (±¸¿¬ ¹ßÇ¥) The predictive accuracy of EULAR defined clinically suspected arthralgia for the development of rheumatoid arthritis: a prospective longitudinal study Cheuk Yin Tam(The Chinese Univ. of Hong Kong, Hong Kong)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 11:00~11:10 (±¸¿¬ ¹ßÇ¥) Exploring risk factors for adverse events and infections in RA and RA with ILD under treatment with biologics or targeted synthetic DMARDs: findings from the KOBIO registry ±èÁö¿ø(¾ÆÁÖ´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 11:10~11:20 (±¸¿¬ ¹ßÇ¥) Comprehensive analysis of patients with rheumatoid arthritis with interstitial lung disease: Clinical characteristics, treatment patterns, and prognostic factors ±èÁö¿ø(¾ÆÁÖ´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 11:20~11:30 (±¸¿¬ ¹ßÇ¥) Risk of anti-rheumatic agents on stroke risk in rheumatoid arthritis: A Korean nationwide case-control study ¾È¼ö¹Î(¿ï»ê´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 11:30~11:40 (±¸¿¬ ¹ßÇ¥) Effects of cumulative lifetime estrogen exposure on the clinical characteristics and courses in postmenopausal women with rheumatoid arthritis ¹ÚÀºÇý(Áß¾Ó´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 11:40~11:50 (±¸¿¬ ¹ßÇ¥) Early-life environmental influences on rheumatoid arthritis risk: Insights from a large retrospective study in Chinese adults Liang Luo(Peking Univ., People)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 11:50~12:00 (±¸¿¬ ¹ßÇ¥) Impact of glucocorticoids on the therapeutic efficacy of denosumab in osteoporosis of rheumatoid arthritis patients ¾çÁö¿ø(°¡Å縯´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 12:00~12:40 Treatment Journey to Protect Bone Fractures È«¼®Âù(¿ï»ê´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 13:00~13:30 Basics of Bone Biology to Understand Osteoporosis Medications ±è¹üÁØ(¿ï»ê´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 13:30~14:00 Real World Evidence of Anabolic Therapy in PMO ±èÇÏ¿µ(¿ï»ê´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 14:00~14:30 Anabolic Treatment for GIOP ¼Ã¢Èñ(¾ÆÁÖ´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 15:30~16:30 Ethical Issues in Clinical Research and Publication È«¼ºÅÂ(¼¿ï´ëÇб³) Çʼö
±³À°½Ã°£ 05¿ù 17ÀÏ Room 2 16:30~17:30 Prevention and Control of Healthcare-associated Infections ÇãÁö¾È(¿µ³²´ëÇб³) Çʼö
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 08:00~08:40 What Distinguishes Secukinumab as an Optimal Choice in AS? ¾È¼º¼ö(¿¬¼¼´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 10:30~10:40 (±¸¿¬ ¹ßÇ¥) Association between metabolic marker and knee osteoarthritis: A cross-sectional study using the Korea National Health And Nutrition Examination survey 2009 to 2013 ÃÖÇöÁØ(µ¿¾Æ´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 10:40~10:50 (±¸¿¬ ¹ßÇ¥) Psychotropic drug use in Korean patients with osteoarthritis ±èÇö¾Æ(ÇѸ²´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 10:50~11:00 (±¸¿¬ ¹ßÇ¥) Comparative effectiveness of yoga and strengthening exercise for treating knee osteoArthritis: A randomised controlled trial (yoga trial) Benny Samuel Eathakkattu Antony(Menzies Institute for Medical Research, Univ. of Tasmania, Australia)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 11:00~11:10 (±¸¿¬ ¹ßÇ¥) Vitamin D deficiency is associated with progression of radiographic hand osteoarthritis in a 6-year follow-up of the Dong-gu study ÃÖ¼ºÀº(Àü³²´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 11:20~11:30 (±¸¿¬ ¹ßÇ¥) GelMA hydrogel microspheres integrating fullerenol and extracellular vesicles alleviate osteoarthritis Tianqi Wang(Yong Loo Lin School of Medicine, National Univ. of Singapore, Singapore)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 11:30~11:40 (±¸¿¬ ¹ßÇ¥) MSC exosomes alleviate osteoarthritis by inhibiting complement activation via CD59-dependent pathway Kristeen Ye Wen Teo(Nat)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 11:40~11:50 (±¸¿¬ ¹ßÇ¥) The interplay between endoplasmic reticulum stress and oxidative stress in chondrocyte catabolism ÇÑÁø(°æºÏ´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 11:50~12:00 (±¸¿¬ ¹ßÇ¥) Therapeutic efficacy and safety of intra articular injection of human bone marrow derived mesenchymal stem cells in cnee osteoarthritis; randomized, double-blind, placebo-controlled clinical trial À̺À¿ì(°¡Å縯´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 12:00~12:40 Treatment Strategies for Improving Patient-specific Care with SIMPONI IV ÀÌ»óÈÆ(°æÈñ´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 13:00~13:10 (±¸¿¬ ¹ßÇ¥) The long-term outcome of renal involvement in primary Sjogren¡¯s syndrome: A possible association with lymphoproliferative disease °íÁ¤Èñ(°¡Å縯´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 13:10~13:20 (±¸¿¬ ¹ßÇ¥) The risk of heart diseases in offspring born to mothers with primary Sjögren Yingbo Zhou(The First Affiliated Hosp. of Univ. of Science and Technology of China, China)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 13:20~13:30 (±¸¿¬ ¹ßÇ¥) Clinical value of salivary gland ultrasonography in evaluating secretory function, disease activity and lymphoma risk factors in primary Sjögren ¾çÁö¿ø(°¡Å縯´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 13:30~13:40 (±¸¿¬ ¹ßÇ¥) Measurement of serum cytokine and chemokine level to predict poor treatment response in patients with inflammatory myositis Á¶¼ºÀÍ(°¡Å縯´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 13:40~13:50 (±¸¿¬ ¹ßÇ¥) Clinical features and treatment strategies associated with relapses of IgG4-related disease: A retrospective multicenter study ¼ÕÇÏÈñ(°¡Å縯´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 13:50~14:00 (±¸¿¬ ¹ßÇ¥) The risk of stroke and myocardial infarction in systemic sclerosis: A population-based study Àº¿µÈñ(¼º±Õ°ü´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 14:00~14:10 (±¸¿¬ ¹ßÇ¥) A glimpse of MRI deep white mater hyperintensities in systemic sclerosis patients Shihan Xu(Peking Union Medical College Hosp., China)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 14:10~14:20 (±¸¿¬ ¹ßÇ¥) Association of vitamin D levels in systemic sclerosis patients: A meta-analysis °Àº¼Û (°í·Á´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 15:30~15:40 (±¸¿¬ ¹ßÇ¥) Mind-body interventions in the management of fibromyalgia: Effects on pain perception, psychological well-being, and quality of life Sahnaz Vivinda Putri(International Univ. Semen Indonesia, Indonesia)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 15:40~15:50 (±¸¿¬ ¹ßÇ¥) Study of quality of life, metabolic and oxidative stress biomarkers In fibromyalgia patients Pardeep Kumar(Biochemistry, F H Medical College & Hosp., India)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 15:50~16:00 (±¸¿¬ ¹ßÇ¥) Exploring arthritis risk factors and their association with metabolic syndrome in Indonesia: Insights from the Indonesia family life study Nadyatul Husna (Alumnus of Universitas Andalas, Indonesia)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 16:00~16:10 (±¸¿¬ ¹ßÇ¥) To characterise cases of de novo check point inhibitor (CPI) induced polyarthritis in cancer patients treated at a tertiary referral centre Jang Yoon(Westmead Hosp., Australia)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 16:30~16:40 (±¸¿¬ ¹ßÇ¥) Human nasal turbinate-derived stem cells with specific gene signatures (HAS2, CXCL1, KRTAP1-5, GSTT2B, and C4B) attenuate rheumatoid arthritis ¹ÎÈ«±â (°Ç±¹´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 16:40~16:50 (±¸¿¬ ¹ßÇ¥) Ganoderic acid ameliorate complete freund adjuvant induced arthritis rats via suppression of HIF-1¥á–VEGF–ANG-1 axis Vikas Kumar(Pharmaceutical Sciences, SAM HIGGINBOTTOM Univ. OF AGRICULTURE, TECHNOLOGY & SCIENCES, India)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 16:50~17:00 (±¸¿¬ ¹ßÇ¥) Cyr61 activates mitochondrial autophagy and regulated the phenotype transformation of rheumatoid arthritis fibroblast-like synoviocytes via the ROS/Hif-1¥á/BNIP3 pathway Yanni Gui(Peking Univ. First Hosp., China)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 17:00~17:10 (±¸¿¬ ¹ßÇ¥) Differential gender effect on rheumatoid arthritis-associated interstitial lung disease and potential steroid hormone mechanisms in SKG mice ±è¹Ì¼Û(°æÈñ´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 17:10~17:20 (±¸¿¬ ¹ßÇ¥) Swimming exercise improves muscle strength and modulates irisin expression to alleviates joint and gut inflammation in curdlan-injected SKG mice Á¶¼º½Å(¼øõÇâ´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 3 17:20~17:30 (±¸¿¬ ¹ßÇ¥) A genome wide association study on ankylosing spondylitis in Koreans identified new susceptibility loci ±¸º»»ê(ÀÎÁ¦´ëÇб³)